Skip to content

Investigating the therapeutic potential of herbal agents on patients with HPV

Investigating the therapeutic potential of herbal agents on patients with HPV

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231111060015N1
Enrollment
30
Registered
2025-02-22
Start date
2025-02-03
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People with skin warts or genital warts. Drug-induced polyneuropathy

Interventions

Intervention 1: Intervention group: Intervention group: patients with HPV topical herbal cream of 50 grams, one gram of shiitake, three grams of moringa extract, one and a half grams of case, two gram

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: People with skin warts between the ages of 18 to 65 People with genital warts between the ages of 18 to 65

Exclusion criteria

Exclusion criteria: Getting pregnant during the intervention Cancer Reluctance to continue participating in the plan History of underlying autoimmune and inflammatory disease

Design outcomes

Primary

MeasureTime frame
Presence or absence of HPV. Timepoint: (before the start of the intervention) and 10 minutes, 1 hour, 1 day and 1 month after the start of using the cream. Method of measurement: The description of the data will be using frequency tables, graphs and indexes of mean, standard deviation, median and interquartile range. In order to test the homogeneity in two groups, if the quantitative variable is normal, we use the independent t-test, and if it is not normal, we use the Mann-Whitney test, and the comparison of the qualitative variables in the two groups is done with the chi-square test or Fisher's exact test. For final analysis and control of intervening variables, we benefit from repeated measures analysis and covariance analysis. The data will be with SPSS software version 25 and the significance level will be 0.005.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Avan

Mashhad University of Medical Sciences

amir_avan@yahoo.com+98 51 3800 2298

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026